Leave Your Message
Hepatobiliary Cancer Detection Solutions
Oncology
Products Categories

Hepatobiliary Cancer Detection Solutions

Our solution provides accurate molecular detection for primary liver cancer (PLC) and biliary tract tumors (BTC), addressing late-stage diagnosis and limited treatment options. By identifying actionable biomarkers, we enable early intervention, targeted therapy selection, and improved disease management—critical for high-mortality hepatobiliary cancers.

    Key Advantages and Benefits

    1. Early & Accurate Diagnosis
    Detects tumors at earlier stages, counteracting the insidious onset (only 10% of PLC patients are surgery-eligible at diagnosis).

    2. Precision Therapy Guidance
    Identifies targets for systemic anti-tumor therapy (advanced PLC) and approved targeted drugs (BTC), improving treatment efficacy.

    3. Improved Prognosis
    Reduces high recurrence rates (67% post-surgery) and extends survival for late-stage patients (50% diagnosed at advanced stage, <1-year survival).

    4. Comprehensive Coverage
    Addresses both PLC (4th most common cancer in China) and BTC, streamlining diagnostics for digestive system malignancies (3% of cases).

    5. Data-Driven Decision-Making
    Supports clinical strategies with biomarker insights, optimizing surgical eligibility, adjuvant therapy, and metastatic management.

    Workflow

    1

    Ordering Information

    Catalog No.

    Product Name

    Specification

    Description

    121020012

    Hepatobiliary Malignant Tumor Gene Mutations Digital PCR Detection Kit

     12r

    Chip matched

    We have a variety of reference materials available, including colour brochures, technical guides, professional literature and operation videos. If you need to consult or obtain relevant materials, please fill in the information below to contact us.